Difference between revisions of "Bill Haseltine"
(Importing from WP and expanding) |
m (→Businessman) |
||
| Line 13: | Line 13: | ||
==Businessman== | ==Businessman== | ||
| − | Dr Haseltine is a founder of several biotechnology companies including Cambridge Biosciences, The Virus Research Institute, ProScript, LeukoSite, Dendreon, Diversa, X-VAX, and Demetrix. He was a founder chairman and CEO of [[Human Genome Sciences]], a company that pioneered the application of genomics to drug discovery. | + | [[Dr Haseltine]] is a founder of several biotechnology companies including Cambridge Biosciences, The Virus Research Institute, ProScript, LeukoSite, Dendreon, Diversa, X-VAX, and Demetrix. He was a founder chairman and CEO of [[Human Genome Sciences]], a company that pioneered the application of genomics to drug discovery. |
==Philanthropist== | ==Philanthropist== | ||
Revision as of 15:13, 22 May 2020
 Dr William Haseltine     (scientist, businessman, author) | |
|---|---|
 | |
| Born | 17 October 1944 St. Louis, Missouri |
| Alma mater | University of California Berkeley, Harvard University, Massachusetts Institute of Technology |
| Member of | Council on Foreign Relations/Members |
William A. Haseltine (born 17 October 1944) is an American scientist, businessman, author, and philanthropist who is known for his groundbreaking work on HIV/AIDS and the human genome.[1] Dr William Haseltine was a professor at Harvard Medical School where he founded two research departments on cancer and HIV/AIDS.
Businessman
Dr Haseltine is a founder of several biotechnology companies including Cambridge Biosciences, The Virus Research Institute, ProScript, LeukoSite, Dendreon, Diversa, X-VAX, and Demetrix. He was a founder chairman and CEO of Human Genome Sciences, a company that pioneered the application of genomics to drug discovery.
Philanthropist
Dr Haseltine is the president of the Haseltine Foundation for Science and the Arts and is the founder, chairman, and president of ACCESS Health International, a not-for-profit organisation dedicated to improving access to high-quality health worldwide. He was listed by Time Magazine as one of the world's 25 most influential business people in 2001 and one of the 100 most influential leaders in biotechnology by Scientific American in 2015.
In April 2020, Dr Haseltine was interviewed on Fox News and said that convalescent antiserum is likely to provide the best protection against COVID-19.[2]
On 24 May 2020, Dr Haseltine tweeted:
Trust in science is being undermined as companies rush to announce breakthroughs without sharing the data behind their findings. Despite the need to find solutions to this pandemic, we cannot give up our standards in the scientific and medical community.[3]
Event Participated in
| Event | Start | End | Location(s) | Description |
|---|---|---|---|---|
| WEF/Annual Meeting/2004 | 21 January 2004 | 25 January 2004 | Switzerland World Economic Forum | 2068 billionaires, CEOs and their politicians and "civil society" leaders met under the slogan Partnering for Prosperity and Security. "We have the people who matter," said World Economic Forum Co-Chief Executive Officer José María Figueres. |
References
This page imported content from Wikipedia on 22 May 2020.Wikipedia is not affiliated with Wikispooks. Original page source here
